Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Good news, bad news from diabetes gathering
Fierce Pharma
Tuesday, June 28, 2011 - 9:26am
tags:
diabetes, Takeda, GSK, Merck, Eli Lilly
Thanks To Icahn, Forest Labs Is Takeover Bait
Pharmalot
Tuesday, June 28, 2011 - 9:24am
tags:
Carl Icahn, M&A, Forest Labs
Vertex Tops Merck in Early Hep C Drug Launch
TheStreet.com
Tuesday, June 28, 2011 - 9:22am
tags:
hepatitis C, Merck, Vertex Pharmaceuticals, Incivek, Victrelis
Eli Lilly Blends 2 Drugs Into 1 in Next Step Forward for Cancer
Bloomberg
Tuesday, June 28, 2011 - 9:21am
tags:
Eli Lilly, cancer
Supreme Court To Review Case On Generic Delays
Pharmalot
Tuesday, June 28, 2011 - 8:57am
tags:
generics, Supreme Court, Caraco, Novo Nordisk, patents, FDA
Supreme Court Won’t Hear Appeal in Lilly Case
WSJ Online
Tuesday, June 28, 2011 - 8:56am
tags:
Eli Lilly, Supreme Court, Zyprexa
5 Dirt Cheap Biotech Stocks Poised to Triple
Seeking Alpha
Tuesday, June 28, 2011 - 8:53am
tags:
Adventrx, Chelsea Therapeutics, Keryx, Palatin, Rexahn
Achillion raises $61M from stock offering
Yahoo/AP
Tuesday, June 28, 2011 - 8:52am
tags:
stock offering, Achillion
Amgen seeks FDA OK to use Xgeva to prevent, delay prostate cancer spread to bones
Yahoo/AP
Tuesday, June 28, 2011 - 8:49am
tags:
Amgen, Xgeva, prostate cancer
Amgen Sells $3 Billion of Bond to Fund Stock Dividend Payments
Bloomberg
Tuesday, June 28, 2011 - 8:43am
tags:
Amgen, dividends, bonds
Novo Nordisk Likely to Profit From Worldwide Growth in Diabetic Treatments
Seeking Alpha
Tuesday, June 28, 2011 - 8:42am
tags:
diabetes, Novo Nordisk
Shire to Produce More Replagal
Yahoo/Zacks.com
Tuesday, June 28, 2011 - 8:41am
tags:
Shire, Replagal, Sanofi, Fabry's disease
How Does Affymetrix Really Boost Its Returns?
Motley Fool
Monday, June 27, 2011 - 6:00pm
tags:
Affymetrix
Busy Week for FDA Leads to Volatile Action in 5 Pharma Stocks
Seeking Alpha
Monday, June 27, 2011 - 5:58pm
tags:
FDA, Durect Corporation, Pain Therapeutics, Acura Pharmaceuticals, Lannett, Fibrocell Science
J&J to link up product marketing
FT.com
Monday, June 27, 2011 - 5:55pm
tags:
JNJ, marketing
AstraZeneca’s Brilinta Worse With High-Dose Aspirin Doses in Analysis
Bloomberg
Monday, June 27, 2011 - 5:53pm
tags:
Brilinta, AstraZeneca, aspirin, Plavix, Sanofi, Bristol-Myers Squibb
Pleasure And Pain For Pfizer
Investopedia
Monday, June 27, 2011 - 5:47pm
tags:
Pfizer, Pain Therapeutics, Durect Corporation, JNJ, Abbott Laboratories, Acura Pharmaceuticals
Biotech Clinical Trials Update for 3 Drug Manufacturers
Seeking Alpha
Monday, June 27, 2011 - 5:44pm
tags:
Pfizer, Cel-Sci, Bristol-Myers Squibb, Eliquis, Multikine
As Ph3 failures spike Big Pharma hits the brakes on R&D spending
Fierce Biotech
Monday, June 27, 2011 - 10:44am
tags:
Big Pharma, R&D
[video] State of Biotech: Human Genome Sciences
CNBC
Monday, June 27, 2011 - 10:42am
tags:
Human Genome Sciences

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.